Tananbaum Steven A.
Reporting owner on Forms 3, 4 and 5, CIK 1435626.
- In the filer group GOLDENTREE ASSET MANAGEMENT LP
Tananbaum Steven A. reported on 2 issuers in 5 filings, the latest a Form 4 filed 2026-10-06.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| QVC Group, Inc. CIK 1254699 | 10% owner | 3 | 2026-10-06 |
| CIK 1567892 | 10% owner | 1 | 2026-10-06 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| QVC Group, Inc. Common Stock | 2026-10-02 | P bought | +250,000 | $13.85 | 11,327,754 | Form 4 |
| QVC Group, Inc. Common Stock | 2026-10-01 | P bought | +848 | $13.6074 | 11,075,730 | Form 4 |
| QVC Group, Inc. Common Stock | 2026-10-01 | P bought | +2,024 | $13.6258 | 11,077,754 | Form 4 |
| QVC Group, Inc. Common Stock | 2026-09-30 | P bought | +2,907 | $13.6134 | 11,074,882 | Form 4 |
| CIK 1567892 Ordinary Shares | 2026-09-24 | P bought | +463,000 | $91 | 8,442,827 | Form 4 |
| QVC Group, Inc. Common Stock | 2026-09-24 | P bought | +80,000 | $14.35 | 11,071,975 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001493152-26-045958 | Keenova Therapeutics plc | 2026-10-06 | ||
| Form 4 0001493152-26-045954 | QVC Group, Inc. | 2026-10-06 | ||
| 13D/A 0001493152-26-045957 | MALLINCKRODT PLC | 2026-10-06 | ||
| Form 4 0001493152-26-045528 | QVC Group, Inc. | 2026-10-02 | ||
| Form 4 0001493152-26-044626 | QVC Group, Inc. | 2026-09-28 |